| New type of interaction between the SARAH domain of the tumour suppressor RASSF1A and its mitotic kinase Aurora A. | None |
| Findings indicate that compared with the alcoholic steatohepatitis (ASH) group of patients, the expression levels of all three tumor suppressor genes (TSGs) proteins, RUNX family transcription factor 3 (RUNX3), glutathione S-transferase pi 1 (GSTP1), and RASSF1A tumor suppressor (RASSF1), were significantly lower in the non-alcoholic steatohepatitis (NASH) group of patients. | None |
| The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium | None |
| MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells | None |
| Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells | None |
| RASSF1A exerts a tumor-suppressing effect by blocking oncogene-mediated JNK activation in lung cells. | lung, |
| Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. | lung, |
| Effect of decitabine pretreatment on sensitivity of bladder cancer cells towards chemotherapeutic drugs was also studied. Decitabine treatment leads to restoration of RASSF1A, activation of hippo pathway followed by decreased expression of its oncogenic downstream targets (CTGF & CYR61). | bladder, |
| RASSF1 A/E is likely to act as a tumor suppressor gene in most pulmonary NET, and RASSF1 C as an oncogene in high-grade tumors. | None |